English
Specials
Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App
Lending
Lending
Go PRO Now
Open App
you are here:

WhiteOak Capital Pharma and Healthcare Fund - Regular Plan - Growth

  • Regular
  • Direct
Category : Sectoral/Thematic
Fund House : YES Asset Management (India) Ltd.
  • NAV
    : ₹ 13.675 -0.17%
    (as on 03rd October, 2025)
Crisil Rating

Not Rated

Rank not available for the fund
Fund Size
: ₹ 423.51 Cr
(0.08% of Investment in Category)
 Expense Ratio
: 2.38%
(2.12% Category average)
Risk-O-Meter
Very High Risk

The fund has 89.71% investment in domestic equities of which 14.62% is in Large Cap stocks, 11.36% is in Mid Cap stocks, 15.42% in Small Cap stocks.The fund has 3.01% investment in Debt, of which 3.01% in Government securities.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Benchmark
    BSE Healthcare TRI
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
₹
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 01st October, 2025)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 24-Sep-25 9864.60 -1.35% - -1.30% 128/242
1 Month 01-Sep-25 9929.70 -0.70% - 0.75% 189/241
3 Month 01-Jul-25 10121.20 1.21% - -1.00% 49/233
6 Month 01-Apr-25 10936.50 9.37% - 10.48% 123/229
YTD 01-Jan-25 9936.90 -0.63% - 1.43% 123/216
1 Year 01-Oct-24 10521.50 5.21% 5.22% -4.72% 15/199
Since Inception 06-Feb-24 13698.00 36.98% 20.98% 11.55% 13/216
Returns Calculator Detailed Returns Analysis

SIP Returns (NAV as on 01st October, 2025)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 01-Oct-24 12000 12559.27 4.66 % 8.75 %
SIP Calculator Detailed Returns Analysis
 

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.

Portfolio (Updated on 31st Aug,2025)

Portfolio Turnover Ratio : 266.00%  |   Category average turnover ratio is 154.05%  
Fund manager updated portfolio more frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for shorter duration than peers)
Equity Holding : 89.71% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 89.71%
No of Stocks : 44 (Category Avg - 44.44) | Large Cap Investments : 14.62%| Mid Cap Investments : 11.36% | Small Cap Investments : 15.42% | Other : 48.31%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Max Healthcare Institute Ltd. Hospital 296 6.99% -0.71% 7.97% (Jun 2025) 2.76% (Sep 2024) 2.56 L 3.30 k
J.b. Chemicals & Pharmaceuticals Ltd. Pharmaceuticals 288 6.80% 2.21% 6.8% (Aug 2025) 0% (Sep 2024) 1.67 L 60.88 k
Fortis Healthcare Ltd. Hospital 265.6 6.27% 0.94% 6.27% (Aug 2025) 1.1% (Sep 2024) 2.91 L 36.86 k
Sun Pharmaceutical Industries Ltd. Pharmaceuticals 257.9 6.09% -0.55% 11.31% (Apr 2025) 6.09% (Aug 2025) 1.62 L 2.52 k
Cipla Ltd. Pharmaceuticals 208.6 4.92% 0.14% 8.07% (Feb 2025) 4.15% (Sep 2024) 1.31 L 5.29 k
Laurus Labs Ltd. Pharmaceuticals 178.2 4.21% -0.23% 4.44% (Jul 2025) 0% (Sep 2024) 2.08 L 0.00
Krishna Institute of Medical Sciences Ltd. Hospital 161.2 3.81% -0.07% 3.91% (Jun 2025) 2.63% (Oct 2024) 2.23 L 11.06 k
Apollo Hospitals Enterprises Ltd. Hospital 138.6 3.27% 0.34% 3.27% (Aug 2025) 2.07% (Oct 2024) 18.22 k 2.23 k
Vijaya Diagnostic Centre Ltd. Healthcare service provider 110.5 2.61% 0.54% 2.61% (Aug 2025) 0.42% (May 2025) 1.10 L 30.70 k
Neuland Laboratories Ltd. Pharmaceuticals 107.1 2.53% 1.06% 2.53% (Aug 2025) 1.3% (Feb 2025) 7.96 k 3.44 k
- indicates change in weight in the portfolio. # indicates a new entry.
Detailed Portfolio Analysis
No of Debt Holding 9 (Category Avg - 1.04) | Modified Duration 0.00 Years (Category Avg - 0.00)| Yield to Maturity - -- (Category Avg - 0.00%)

Type of Holdings

Security Type
% Weight
Category Average
GOI 0.00% 0.01%
T-Bills 3.01% 0.47%

Investment / Portfolio Grades

Security Type
% Weight
Category Average
Government Backed 3.01% 0.48%
Low Risk 0.00% 0.00%
Moderate Risk 0.00% 0.00%
High Risk 0.00% 0.00%
Very High Risk 0.00% 0.00%
Others 0.00% 0.00%
Detailed Portfolio Analysis
Name Type of Instrument Weight (%)
TREPS TREPS 7.00%
Net Receivables Net Receivables 0.28%
Detailed Portfolio Analysis

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)

    No data available. Ratios are only available for the funds which are 3 years old.

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Nippon India Taiwan Equity Fund - Regular Plan - Growth NA 389.09 7.68 23.98 68.86 45.59 37.55
Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth NA 249.75 2.83 10.46 22.12 26.05 20.21
Nippon India US Equity Opportunities Fund - Growth NA 713.51 1.87 4.25 12.16 15.86 22.48
Nippon India Japan Equity Fund - Growth NA 283.56 1.59 8.27 19.74 13.00 19.41
Franklin Asian Equity Fund - Growth NA 259.99 4.90 8.94 19.32 11.64 14.50
SBI Banking & Financial Services Fund - Regular Plan - Growth NA 8370.76 3.21 -1.22 12.86 9.76 19.63
Motilal Oswal Business Cycle Fund - Regular Plan - Growth NA 1976.19 -3.14 -1.63 8.60 7.54 0.00
DSP Banking & Financial Services Fund - Regular Plan - Growth NA 1331.23 3.66 -1.67 10.50 6.95 0.00
ICICI Prudential US Bluechip Equity Fund - Growth NA 3356.51 0.09 5.87 14.71 6.46 19.97
HDFC Transportation and Logistics Fund - Regular Plan - Growth NA 1533.43 2.03 12.17 31.33 5.87 0.00

More Funds from YES Asset Management (India) Ltd.

Out of 20 mutual fund schemes offered by this AMC, 1 is/are ranked 4 * , and 19 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
WhiteOak Capital Flexi Cap Fund - Regular Plan - Growth NA 5743.69 0.40 -1.69 10.50 -1.21 18.82
WhiteOak Capital Mid Cap Fund - Regular Plan - Growth NA 3581.58 0.05 -0.93 15.49 0.98 24.34
WhiteOak Capital Multi Asset Allocation Fund - Regular Plan - Growth NA 3421.65 0.00 0.00 0.00 0.00 0.00
WhiteOak Capital Multi Asset Allocation Fund - Regular Plan - Growth NA 3421.65 1.97 3.10 9.64 13.13 0.00
WhiteOak Capital Multi Cap Fund - Regular Plan - Growth NA 2261.56 0.23 -0.90 13.43 1.26 0.00
WhiteOak Capital Balanced Advantage Fund - Regular Plan - Growth NA 1811.88 0.32 -0.92 7.28 2.97 0.00
WhiteOak Capital Large & Mid Cap Fund - Regular Plan - Growth NA 1781.23 0.45 -1.62 12.03 -0.58 0.00
WhiteOak Capital Special Opportunities Fund - Regular Plan - Growth NA 1132.28 -0.12 -1.76 13.09 1.57 0.00
WhiteOak Capital Large Cap Fund - Regular Plan - Growth NA 1014.17 0.65 -1.86 9.23 -1.64 0.00
WhiteOak Capital Quality Equity Fund - Regular Plan - Growth NA 594.70 -1.48 -3.31 6.10 0.00 0.00
All funds

Forum

POST

+ See More

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347